Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02449681
Title Study for Treatment of Patients With Recurrent or Metastatic SCCHN or SCCS
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Threshold Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | AUS


No variant requirements are available.